Maravai LifeSciences Holdings (MEX:MRVI) Retained Earnings: MXN115 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MRVI Maravai LifeSciences Holdings Inc MEX:MRVI
54 GF Score
Price MXN85.00
GF Value MXN49.44
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Retained Earnings?

Maravai LifeSciences Holdings MEX:MRVI 54 Retained Earnings is MXN115 Mil as of Mar. 2026. GuruFocus rates MEX:MRVI with a GF Score™ of 54/100 and a GF Value™ of MXN49.44. The stock has 8 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Maravai LifeSciences Holdings's retained earnings for the quarter that ended in Mar. 2026 was MXN115 Mil.

Maravai LifeSciences Holdings's quarterly retained earnings declined from Sep. 2025 (MXN840 Mil) to Dec. 2025 (MXN182 Mil) and declined from Dec. 2025 (MXN182 Mil) to Mar. 2026 (MXN115 Mil).

Maravai LifeSciences Holdings's annual retained earnings declined from Dec. 2023 (MXN4,850 Mil) to Dec. 2024 (MXN2,938 Mil) and declined from Dec. 2024 (MXN2,938 Mil) to Dec. 2025 (MXN182 Mil).


Maravai LifeSciences Holdings  (MEX:MRVI) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Maravai LifeSciences Holdings Retained Earnings Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Retained Earnings Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial 3,786.08 7,891.32 4,850.17 2,938.38 182.18

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,269.76 1,343.56 840.15 182.18 115.14
MEX:MRVI
54GF Score
Maravai LifeSciences Holdings Inc MEX:MRVI
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maravai LifeSciences Holdings Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of MXN115 Mil mean?
Maravai LifeSciences Holdings (MEX:MRVI) has a Retained Earnings of MXN115 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Maravai LifeSciences Holdings and its competitors.
Is Maravai LifeSciences Holdings' Retained Earnings too high?
Maravai LifeSciences Holdings' current Retained Earnings is MXN115 Mil. Overall, Maravai LifeSciences Holdings has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Retained Earnings compare to LBRX and AVTX?
Maravai LifeSciences Holdings' Retained Earnings of MXN115 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current Retained Earnings is MXN115 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Retained Earnings of MXN115 Mil. The stock's GF Value™ is MXN49.44, compared to a current price of MXN85.00 — trading 71.9% above its estimated fair value. The current Retained Earnings is MXN115 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Retained Earnings is MXN115 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of MXN85.00 is trading 71.9% above its estimated GF Value™ of MXN49.44.

Key valuation signals for MEX:MRVI:

  • Retained Earnings: MXN115 Mil
  • GF Value™: MXN49.44 vs. price of MXN85.00 (71.9% above fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
54GF Score

Get the complete analysis for MEX:MRVI

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.00
Price
MXN49.44
GF Value